Published May 31, 2024 | Version https://impactfactor.org/PDF/IJPCR/16/IJPCR,Vol16,Issue5,Article460.pdf
Journal article Open

Association between Oropharyngeal Ph Monitoring, Pepsin Saliva Concentration and Degree of Apnea and Hypopnea Index of Obstructive Sleep Apnea

Authors/Creators

  • 1. Assistant Professor, Department of Otorhinolaryngology, Narayan Medical College and Hospital, Jamuhar Sasaram, Bihar, India
  • 2. Assistant Professor, Department of Otorhinolaryngology, Uttar Pradesh University of Medical Sciences, Saifai, Etawah, India
  • 3. Professor and HOD, Department of Otorhinolaryngology, Narayan Medical College and Hospital, Jamuhar Sasaram, Bihar, India
  • 4. Junior Resident, Department of Otorhinolaryngology, Narayan Medical College and Hospital, Jamuhar Sasaram, Bihar, India

Description

Objective: To investigate the association between obstructive sleep apnea (OSA) and laryngopharyngeal reflux (LPR) through oropharyngeal pH-monitoring and pepsin saliva measurements. Methods: Patients with sleep disturbances and reflux symptoms underwent polysomnography, 24-h oropharyngeal pH-monitoring and saliva pepsin collections. The prevalence of LPR was investigated in OSA patients according to oropharyngeal pH-monitoring and pepsin measurements. A correlation analysis was performed between pH-monitoring findings, pepsin saliva levels, reflux symptom score-12 (RSS-12), reflux sign assessment (RSA), Apnea–Hypopnea Index (AHI), Epworth Sleepiness Scale, Pichot and arousal findings. Results: Thirty-seven patients completed the evaluations. LPR was detected in 34/37 (92%) and 29/34 (85%) patients at the oropharyngeal-pH monitoring and pepsin test, respectively. OSA was detected in 30 patients (81%). Among them, LPR was detected in 28/30 (93%) cases. Pharyngeal reflux events mainly occurred nighttime/supine in OSA patients. Both Ryan score and supine reflux time at pH < 6.5 were significantly associated with BMI and the RSA sub- and total scores (p < 0.02). Tongue-base hypertrophy score was positively associated with the number of micro-arousals (p =&thinsp;0.027); the supine percent of pH < 6.5 (p =&thinsp;0.030); morning (p =&thinsp;0.030) and bedtime pepsin saliva measurements (p =&thinsp;0.037). The bedtime pepsin saliva level was significantly associated with Ryan Score (p =&thinsp;0.047); AHI (p =&thinsp;0.017) and the sleep saturation < 90% time (p =&thinsp;0.040). The saliva level of the morning pepsin was associated with a shortest paradoxical sleep phase (p =&thinsp;0.013). Conclusion: OSA patients may have high prevalence of pharyngeal reflux events at the oropharyngeal pH-monitoring and high pepsin saliva measurements. Oropharyngeal pH-monitoring should be useful for the correlation between reflux and sleep findings in OSA patients. Future large cohort controlled studies are needed to determine the prevalence of LPR in OSA and healthy individuals.

 

 

 

Abstract (English)

Objective: To investigate the association between obstructive sleep apnea (OSA) and laryngopharyngeal reflux (LPR) through oropharyngeal pH-monitoring and pepsin saliva measurements. Methods: Patients with sleep disturbances and reflux symptoms underwent polysomnography, 24-h oropharyngeal pH-monitoring and saliva pepsin collections. The prevalence of LPR was investigated in OSA patients according to oropharyngeal pH-monitoring and pepsin measurements. A correlation analysis was performed between pH-monitoring findings, pepsin saliva levels, reflux symptom score-12 (RSS-12), reflux sign assessment (RSA), Apnea–Hypopnea Index (AHI), Epworth Sleepiness Scale, Pichot and arousal findings. Results: Thirty-seven patients completed the evaluations. LPR was detected in 34/37 (92%) and 29/34 (85%) patients at the oropharyngeal-pH monitoring and pepsin test, respectively. OSA was detected in 30 patients (81%). Among them, LPR was detected in 28/30 (93%) cases. Pharyngeal reflux events mainly occurred nighttime/supine in OSA patients. Both Ryan score and supine reflux time at pH < 6.5 were significantly associated with BMI and the RSA sub- and total scores (p < 0.02). Tongue-base hypertrophy score was positively associated with the number of micro-arousals (p =&thinsp;0.027); the supine percent of pH < 6.5 (p =&thinsp;0.030); morning (p =&thinsp;0.030) and bedtime pepsin saliva measurements (p =&thinsp;0.037). The bedtime pepsin saliva level was significantly associated with Ryan Score (p =&thinsp;0.047); AHI (p =&thinsp;0.017) and the sleep saturation < 90% time (p =&thinsp;0.040). The saliva level of the morning pepsin was associated with a shortest paradoxical sleep phase (p =&thinsp;0.013). Conclusion: OSA patients may have high prevalence of pharyngeal reflux events at the oropharyngeal pH-monitoring and high pepsin saliva measurements. Oropharyngeal pH-monitoring should be useful for the correlation between reflux and sleep findings in OSA patients. Future large cohort controlled studies are needed to determine the prevalence of LPR in OSA and healthy individuals.

 

 

 

Files

IJPCR,Vol16,Issue5,Article460.pdf

Files (382.4 kB)

Name Size Download all
md5:b16f6de8ebbc81910a273c377b2bbfc2
382.4 kB Preview Download

Additional details

Identifiers

URL
https://impactfactor.org/PDF/IJPCR/16/IJPCR,Vol16,Issue5,Article460.pdf

Dates

Accepted
2024-05-21

Software

Repository URL
https://impactfactor.org/PDF/IJPCR/16/IJPCR,Vol16,Issue5,Article460.pdf
Development Status
Active

References

  • 1. Lechien JR, Akst LM, Hamdan AL, Schindler A, Karkos PD, Barillari MR, Calvo-Henriquez C, Crevier-Buchman L, Finck C, Eun YG, Saussez S, Vaezi MF. Evaluation and management of laryngopharyngeal refux disease: state of the art review. Otolaryngol Head Neck Surg. 2019;160(5):762–82. https://doi.org/10. 1177/ 0194599819827488. 2. Lechien JR, Hans S, Simon F, Horoi M, Calvo-Henriquez C, Chiesa-Estomba CM, MayoYáñez M, Bartel R, Piersiala K, Nguyen Y, Saussez S. Association between laryngopharyngeal refux and media otitis: a systematic review. Otol Neurotol. 2021;42(7):e801–14. https://doi.org/10.1097/MAO.0000000000003 123. 3. Ren JJ, Zhao Y, Wang J, Ren X, Xu Y, Tang W, He Z. PepsinA as a marker of laryngopharyngeal refux detected in chronic rhinosinusitis patients. Otolaryngol Head Neck Surg. 2017; 156(5):893–900. https://doi.org/10.1177/0194 599817697055. 4. Halstead LA. Gastroesophageal refux: a critical factor in pediatric subglottic stenosis. Otolaryngol Head Neck Surg. 1999;120(5):683–8. https://doi. org/10.1053/hn.1999.v120.a91766. 5. Kayalı Dinc AS, Cayonu M, Sengezer T, Sahin MM. Smoking cessation improves the symptoms and the fndings of laryngeal irritation. Ear Nose Throat J. 2020;99(2):124–7. https:/ /doi.org/10.1177/0145561319881559. 6. Lechien JR, Huet K, Khalife M, Fourneau AF, Delvaux V, Piccaluga M, Harmegnies B. Saussez S Impact of laryngopharyngeal refux on subjective and objective voiceassessments: a prospective study. J Otolaryngol Head Neck Surg. 2016;45(1):59. https://doi.org/10.1186/ s40463-016-0171-1. 7. O'Connor-Reina C, Garcia JMI, Baptista P, Garcia-Iriarte MT, Alba CC, Perona M, Borrmann PF, Alcala LR, Plaza G. Non-acid refux and sleep apnea: the importance of drug induced sleep endoscopy. J Otolaryngol Head Neck Surg. 2021;50(1):42. https://doi.org/10.1 186/ s40463-021-00526-w. 8. Suurna MV, Welge J, Surdulescu V, Kushner J, Steward DL. Randomized placebocontrolled trial of pantoprazole for daytime sleepiness in GERD and obstructive sleep disordered breathing. Otolaryngol Head Neck Surg. 2008;139(2):286–90. https://doi.org/10. 1016/j.otohns.2008.03.012. 9. Teklu M, Gouveia CJ, Yalamanchili A, Ghadersohi S, Price CPE, Bove M, Attarian HP, Tan BK. Predicting obstructive sleep apnea status with the refux symptom index in a sleep study population. Laryngoscope. 2020. https://doi.org/10.1002/lary.28592. 10. Lechien JR, Bobin F, Rodriguez A, Dequanter D, Muls V, Huet K, Harmegnies B, CrevierBuchman L, Hans S, Saussez S, Carroll TL. Development and validation of the short version of the refux symptom score: refux symptom score-12. Otolaryngol Head Neck Surg. 2021;164(1):166–74. https://doi.org/10.1177/ 019459 9820941003. 11. Berry RB, Budhiraja R, Gottlieb DJ, et al. Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. Deliberations of the sleep apnea defnitions task force of the American academy of sleep medicine. J Clin Sleep Med. 2012;8(5):597–619. https:// doi.org/10.5664/jcsm.2172.12. Lechien JR, Finck C, Huet K, Khalife M, Fourneau AF, Delvaux V, Piccaluga M, Harmegnies B, Saussez S. Impact of age on laryngopharyngeal refux disease presentation: a multi-center prospective study. Eur Arch Otorhinolaryngol. 2017;274(10):3687–96. 13. Lechien JR, Rodriguez Ruiz A, Dequanter D, Bobin F, Mouawad F, Muls V, Huet K, Harmegnies B, Remacle S, Finck C, Saussez S. Validity and reliability of the refux sign assessment. Ann Otol Rhinol Laryngol. 2020;12 9(4):313–25. https://doi.org/10.1177/0003489419888947. 14. Lechien JR, Chan WW, Akst LM, Hoppo T, Jobe BA, Chiesa-Estomba CM, Muls V, Bobin F, Saussez S, Carroll TL, Vaezi MF, Bock JM. Normative ambulatory refux monitoring metrics for laryngopharyngeal refux: a systematic review of 720 healthy individuals. Otolaryngol Head Neck Surg. 2021. https://doi.org/10.1 177/01945998211029831. 15. Bobin F, Journe F, Lechien JR. Saliva pepsin level of laryngopharyngeal refux patients is not correlated with refux episodes. Laryngoscope. 2020;130(5):1278–81. https://doi.org/10.1002/lary.28260. 16. Lechien JR, Bobin F, Dequanter D, Rodriguez A, Le Bon S, Horoi M, Thill MP, Salem C, Muls V, Saussez S. Does pepsin saliva concentration (peptest™) predict the therapeutic response of laryngopharyngeal refux patients? Ann Otol Rhinol Laryngol. 2021;130(9):996– 1003. https://doi.org/10.1177/ 0003489420986 347. 17. Kaminska M, Jobin V, Mayer P, Amyot R, Perraton-Brillon M, Bellemare F. The epworth sleepiness scale: self-administration versus administration by the physician, and validation of a French version. Can Respir J. 2010;17(2): e27-34. https://doi.org/10.1155/2010/438676. 18. Pichot P, Brun JP. Brief self-evaluation questionnaire for depressive, asthenic and anxious dimensions. Ann Med Psychol (Paris). 1984;14 2(6):862–5. 19. Bobin F, Auregan G, Muls V, Cammaroto G, Hans S, Saussez S, Lechien JR. Impedance-pH monitoring profle of patients with refux and obstructive sleep apnea syndrome: a controlled study. Clin Otolaryngol. 2021;46(4):816–22. https://doi.org/10.1111/coa.13745. 20. Elhennawi DM, Ahmed MR, Abou-Halawa AS. Correlation of obstructive sleep apnoea and laryngopharyngeal refux: phmetry study. Clin Otolaryngol. 2016;41(6):758–61. https:// doi.org/10.1111/coa.12640. 21. Xiao YL, Liu FQ, Li J, Lv JT, Lin JK, Wen WP, Chen MH. Gastroesophageal and laryngopharyngeal refux profles in patients with obstructive sleep apnea/hypopnea syndrome as determined by combined multichannel intraluminal impedance-pH monitoring. Neurogastroenterol Motil. 2012;24(6):e258–65. https ://doi.org/10.1111/j.1365-2982.2012.01920.x. 22. Erdem D, Yılmaz YF, Özcan M, Titiz A, Özlügedik S, Ünal A. Correlation of sleepdisordered breathing and laryngopharyngeal refux: a two-channel triple-sensor pHmetry catheter study. Eur Arch Otorhinolaryngol. 2018;275(10):2585–92. https://doi.org/10.100 7/s00 405-018-5107-0. 23. Xavier SD, Eckley CA, Duprat AC, de Souza Fontes LH, Navarro-Rodriguez T, Patrocínio J, Tridente D, Lorenzi-Filho G. Temporal association between respiratory events and refux in patients with obstructive sleep apnea and laryngopharyngeal refux. J Clin Sleep Med. 20 19;15(10):1397–402. https://doi.org/10.5664/jcsm.7960. 24. Kamani T, Penney S, Mitra I, Pothula V. The prevalence of laryngopharyngeal refux in the English population. Eur Arch Otorhinolaryngol. 2012;269(10):2219–25. 25. Spantideas N, Drosou E, Bougea A, Assimakopoulos D. Laryngopharyngeal refux disease in the Greek general population, prevalence and risk factors. BMC Ear Nose Throat Disord. 2015; 15:7. 26. Connor NP, Palazzi-Churas KL, Cohen SB, et al. Symptoms of extraesopha - geal refux in a community – dwelling sample. J Voice. 2007; 21:189–202. 27. Wang L, Han H, Wang G, Liu H, Sun Z, Li B, Sui X, Du F, Zhong C, Wu W. Relationship between refux diseases and obstructive sleep apnea together with continuous positive airway pressure treatment efciency analysis. Sleep Med. 2020; 75:151–5. https://doi.org/10.1016/j .sleep.2020. 07.024. 28. Müller DT, Schulte E, Babic B, Knepper L, Fuchs C, Schröder W, Bruns CJ, Leers JM, Fuchs HF. Software improvement for evaluation of laryn - gopharyngeal pH testing (Restech) - a comparison between DataView 3 and 4. World J Gastrointest Surg. 2020;12(5): 236–46. https://doi.org/10. 4240/wjgs.v12.i5. 236 . 29. Sikavi DR, Cai JX, Leung R, Carroll TL, Chan WW. Impaired proximal esophageal contractility predicts pharyngeal refux in patients with lar - yngopharyngeal refux symptoms. Clin Transl Gastroenterol. 2021;12(10): e00408. https://doi.org/10.14309/ctg.000000000000040 8. 30. Ing AJ, Ngu MC, Breslin AB. Obstructive sleep apnea and gastroesopha - geal refux. Am J Med. 2000;108(Suppl. 4a):120S-125S. 31. Sung MW, Lee WH, Wee JH, Lee CH, Kim E, Kim JW. Factors associated with hypertrophy of the lingual tonsils in adults with sleepdisordered breathing. JAMA Otolaryngol HeadNeck Surg. 2013;139(6):598–603. https://doi. org/10.1001/jamaoto.2013.3263. 32. Ermis F, Akyuz F, Arici S, Uyanikoglu A, Yakar F, Pinarbasi B, Demir K, Ozdil S, Besisik F, Kaymakoglu S, Boztas G, Cuhadaroglu C, Mungan Z. Efect of proton pump inhibitor (PPI) treatment in obstructive sleep apnea syndrome: an esophageal impedance-pHmetry study. Hepatogastroen - terology. 2011;58 (11 0–111):1566–73. https://doi.org/10.5754/hge 10465. 33. Wise SK, Wise JC, Del Gaudio JM. Gastroesophageal refux and laryn - gopharyngeal refux in patients with sleep-disordered breathing. Oto - laryngol Head Neck Surg. 2006; 135(2):253–7. https://doi.org/10.1016/j. otoh ns.2006.05.012 . 34. Rodrigues MM, Dibbern RS, Santos VJ, et al. Infuence of obesity on the correlation between laryngopharyngeal refux and obstructive sleep apnea. Braz J Otorhinolaryngol. 2014; 80:5– 10. 35. Lechien JR. Clinical update fndings about pHimpedance moni - toring features in laryngopharyngeal refux patients. J Clin Med. 202 2;11(11):3158. https://doi.org/10.3390/jcm111 13158. 36. Vance D, Park J, Alnouri G, Turner RR, Daggumati S, Ferster APO, Ahmad A, Lyons K, Ross J, Russell K, Wu W, Satalof RT. Diagnosing laryngopharyn - geal refux: a comparison between 24-hour pH-impedance testing and pharyngeal probe (restech) testing, with introduction of the satalof score. J Voice. 2021; S0892–1997(21):00136–43. https://doi. org/10.1016/j. jvoice.2021.04.002.